These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 5566032

  • 1. [Experimental neoplasms induced by alkylating cytostatics and alkylating antibiotics].
    Roth J.
    Hippokrates; 1971 Jun; 42(2):231-3. PubMed ID: 5566032
    [No Abstract] [Full Text] [Related]

  • 2. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
    Schmähl D.
    Internist (Berl); 1971 Jun; 12():Suppl 1:115-9. PubMed ID: 5002614
    [No Abstract] [Full Text] [Related]

  • 3. [Drug therapy in pulmonary neoplasms].
    Cairella M, Marasà G.
    Clin Ter; 1970 Jul 31; 54(2):163-79. PubMed ID: 5476350
    [No Abstract] [Full Text] [Related]

  • 4. The pharmacology of immunosuppressive agents.
    Mitchell MS, Bertino JR.
    Conn Med; 1970 Dec 31; 34(12):843-50. PubMed ID: 4923392
    [No Abstract] [Full Text] [Related]

  • 5. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.
    Schabel FM.
    Cancer Res; 1969 Dec 31; 29(12):2384-9. PubMed ID: 5369685
    [No Abstract] [Full Text] [Related]

  • 6. [Chemotherapy of stomach cancer].
    Omuraliev A.
    Vopr Onkol; 1980 Dec 31; 26(5):89-99. PubMed ID: 6770542
    [No Abstract] [Full Text] [Related]

  • 7. [Cytostatic therapy in solid tumors].
    Dold U.
    Anasthesiol Intensivmed Prax; 1979 Feb 31; 16():99-109. PubMed ID: 434420
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA, Hall TC, Sherman CD, Savlov ED.
    Am J Med Sci; 1969 Oct 31; 258(4):245-59. PubMed ID: 5823461
    [No Abstract] [Full Text] [Related]

  • 9. [Modern therapy with cytostatics in gynecology].
    Popović D, Berić B, Popović I, Stefanović O.
    Med Pregl; 1969 Oct 31; 22(7):413-8. PubMed ID: 5201408
    [No Abstract] [Full Text] [Related]

  • 10. [Carcinogenic effects of antineoplastic and immunosuppressive agents].
    Brock N, Schneider H.
    Arzneimittelforschung; 1971 Sep 31; 21(9):1406-10. PubMed ID: 5171799
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of antineoplastic drugs on blood and tumor water-electrolyte balance in mice and rats].
    Pashinskiĭ BG.
    Vopr Onkol; 1969 Sep 31; 15(6):65-8. PubMed ID: 5820355
    [No Abstract] [Full Text] [Related]

  • 12. [Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
    Belousova AK.
    Vopr Onkol; 1978 Sep 31; 24(5):92-104. PubMed ID: 351956
    [No Abstract] [Full Text] [Related]

  • 13. [Antitumor chemotherapy. Trial and results of a new antineoplastic agent with a double mechanism of alkylating and antimetabolic action].
    Battaglia L.
    Clin Ter; 1974 Dec 31; 71(6):573-93. PubMed ID: 4448054
    [No Abstract] [Full Text] [Related]

  • 14. [The method of regional limb perfusion using cytostatics].
    Tomsú M, Wágner K.
    Acta Chir Orthop Traumatol Cech; 1966 Jun 31; 33(3):261-2. PubMed ID: 5963824
    [No Abstract] [Full Text] [Related]

  • 15. Tests for chemical carcinogens. Report on the activity of derivatives of aromatic amines, nitrosamines, quinolines, nitroalkanes, amides, epoxides, aziridines, and purine antimetabolites.
    Hadidian Z, Fredrickson TN, Weisburger EK, Weisburger JH, Glass RM, Mantel N.
    J Natl Cancer Inst; 1968 Oct 31; 41(4):985-1036. PubMed ID: 5686039
    [No Abstract] [Full Text] [Related]

  • 16. Investigations on the influence of immunodepressive means on the chemical carcinogenesis in rats.
    Schmähl D.
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Oct 31; 81(3-4):211-5. PubMed ID: 4279516
    [No Abstract] [Full Text] [Related]

  • 17. [PROBLEMS IN ACQUIRED RESISTANCE OF TUMORS TOWARDS CYTOSTATICS].
    UJHAZY V.
    Bratisl Lek Listy; 1964 Oct 31; 44():562-8. PubMed ID: 14160201
    [No Abstract] [Full Text] [Related]

  • 18. [Mixed, Yoshida-type tumors, resistant and sensitive to alkylating agents].
    Winkler A, Ujházy V, Sándor L, Drahovský D.
    Cas Lek Cesk; 1966 Sep 23; 105(39):1068-71. PubMed ID: 5976461
    [No Abstract] [Full Text] [Related]

  • 19. Carcinogenicity of anticancer drugs and especially alkylating agents.
    Schmähl D.
    IARC Sci Publ; 1986 Sep 23; (78):29-35. PubMed ID: 3583394
    [No Abstract] [Full Text] [Related]

  • 20. Ultrastructural alterations induced by alkylating agent (R-74) in tumour cells.
    Lapis K, Benedeczky I, Bolla K.
    Acta Biol Acad Sci Hung; 1967 Sep 23; 18(3):303-22. PubMed ID: 5600538
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.